Patients in the control group were administrated rt-PA ( 0/9 mg/kg ) while patients in the experimental group were given urinary kallidinogenase by intravenous drip ( 0.15 PNAU/d , for 7 days ) after rt-PA intravenous thrombolytic treatment ( 0.9 mg/kg ) .